values are 1 and 11 μ
M respectively) that displays no activity at p38γ
and a range of other kinases. Potently inhibits TNF-α
values are 3 and 11 nM respectively) and suppresses HIV-1 replication in T cells in vitro
. Displays cardioprotective and anti-inflammatory activity in vivo
. Orally active.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Suppresssion of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor.
Muthumani et al.
p38 mitogen activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling fowllowing myocardial infarction in the rat.
See et al.
RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
Wadsworth et al.